(Q45199713)

10 December 2017

title

Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy (English)

1 reference

10 December 2017

1 reference

10 December 2017

S Thiel

0 references

FinnDiane Study Group

object named as

FinnDiane Study Group

1 reference

10 December 2017

A Flyvbjerg

1 reference

10 December 2017

M Saraheimo

1 reference

10 December 2017

C Forsblom

1 reference

10 December 2017

T K Hansen

1 reference

10 December 2017

A-M Teppo

1 reference

10 December 2017

J Fagerudd

1 reference

10 December 2017

K Pettersson-Fernholm

1 reference

10 December 2017

P Ebeling

1 reference

10 December 2017

P-H Groop

1 reference

10 December 2017

language of work or name

1 reference

23 December 2004

1 reference

10 December 2017

1 reference

10 December 2017

1 reference

10 December 2017

1 reference

10 December 2017

page(s)

198-202

1 reference

Mannan-binding lectin: clinical significance and applications

10 December 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-004-1594-1

Matrix remodelling enzymes, the protease cascade and glycosylation

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-004-1594-1

Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study

21 January 2018

1 reference

12 December 2020

Complement regulation in innate immunity and the acute-phase response: inhibition of mannan-binding lectin-initiated complement cytolysis by C-reactive protein (CRP)

1 reference

12 December 2020

The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein

1 reference

12 December 2020

Assays for the functional activity of the mannan-binding lectin pathway of complement activation

1 reference

12 December 2020

Can clinical factors estimate insulin resistance in type 1 diabetes?

1 reference

12 December 2020

Deposition of mannan binding protein and mannan binding protein-mediated complement activation in the glomeruli of patients with IgA nephropathy

1 reference

12 December 2020

Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients

1 reference

12 December 2020

Prediction of creatinine clearance from serum creatinine

1 reference

12 December 2020

Complement activation through the lectin pathway in patients with Henoch-Schönlein purpura nephritis

1 reference

12 December 2020

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X

1 reference

12 December 2020

Biochemistry and genetics of mannan-binding lectin (MBL).

1 reference

12 December 2020

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death

1 reference

12 December 2020

Isolation and characterization of a mannan-binding protein from rabbit serum

1 reference

12 December 2020

Ancient origin of the complement lectin pathway revealed by molecular cloning of mannan binding protein-associated serine protease from a urochordate, the Japanese ascidian, Halocynthia roretzi

1 reference

12 December 2020

Elevated levels of mannan-binding lectin in patients with type 1 diabetes

1 reference

12 December 2020

Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study

1 reference

12 December 2020

10.1007/S00125-004-1594-1

Identifiers

DOI

1 reference

Dimensions Publication ID

10 December 2017

1042198129

0 references

1 reference